Work

InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity

Year: 2015

Type: review

Source: Cancer Letters

DOI: 10.1016/j.canlet.2015.01.029

Authors: Feifan Zhou, Xiaosong Li, Mark F. Naylor, Tomas Hode, Robert E. Nordquist, Luciano Alleruzzo, Joseph Raker, Samuel S.K. Lam, Nan Du, Lei Shi, Xiuli Wang, Wei R. Chen

Institutions: University of Central Oklahoma, Chinese PLA General Hospital, First Affiliated Hospital of Chinese PLA General Hospital, Shanghai Skin Disease Hospital

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, National Institutes of Health, Beijing Nova Program, National Institute of Biomedical Imaging and Bioengineering

Awards: G148018023, G1845438514, G288737496, A Novel Multifunctional Bionanoprobe-Based Phototherapy for Metastatic Cancers, G5289221039, 激光原位免疫疗法重建恶黑患者抗肿瘤免疫系统的机制研究, G870495723

OpenAlex ID: W2095915853

FWCI: 0.734

Cites: 99

Cited by: 81

Related to: 10